GLIVEC cpr pell 400 mg sécables 30 pce

7680563950061 CH-56395 L01EA01 07.16.1.

Active substances:

GLIVEC cpr pell 400 mg sécables 30 pce
GLIVEC cpr pell 400 mg sécables 30 pce
1 / 2
google

Details

Product number
5639503
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
imatinibum 400 mg ut imatinibi mesilas, cellulosum microcristallinum, crospovidonum, hypromellosum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, E 172 (flavum), E 172 (rubrum), macrogolum 4000, talcum, pro compresso obducto.

Articles (1)

Glivec 400 mg, Filmtabletten (teilbar)
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/09/2026
Patient information leaflet
Français
08/09/2026
Patient information leaflet
Italien
08/09/2026
Professional SmPC
Allemand
08/09/2026
Professional SmPC
Français
08/09/2026
Professional SmPC
Italien
08/09/2026

Detailed composition

Substance Quantity Type Category
imatinibum
400.0 MG Substance Wirkstoff (Principe actif)
imatinibi mesilas
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
crospovidonum
- Substance HNIDK
hypromellosum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
macrogolum 4000
- Substance HNIDK
talcum
- Substance HNIDK

Reimbursement information

Public price
CHF 1730.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2009

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
56395
Drug name
Glivec, Filmtabletten
Galenic form
FILM
ATC Code
L01EA01
Authorization status
Z
Dispensation category
A
First authorization
24/09/2003
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum Ph+ chronische myeloische Leukämie (Ph+CML) Ph+ akute lymphatische Leukämie (Ph+ALL) Hypereosinophilensyndrom (HES/CEL) Atypische myelodysplastische/myeloproliferative Erkrankungen (MDS/MPD) Aggressive systemische Mastozytose (aggr. SM) Gastrointestinale Stromatumoren (GIST) Dermatofibrosarkom protuberans (DFSP) (für genaue Angaben zur Indikation siehe aktuelle Fachinformation)

Packaging details

Description (FR)
GLIVEC cpr pell 400 mg sécables 30 pce
Description (DE)
GLIVEC Filmtabl 400 mg teilbar 30 Stk
Market launch
16/01/2009
Narcotic (BTM)
No

Available generics

Imatinib Accord, Filmtabletten
CHF 518.95
View
Imatinib Accord, Filmtabletten
CHF 679.70
View
Imatinib Accord, Filmtabletten
CHF 1020.45
View
Imatinib Accord, Filmtabletten
CHF 2576.75
View
Imatinib GIST-Teva, Filmtabletten
CHF 581.10
View
Imatinib GIST-Teva, Filmtabletten
CHF 1129.80
View
Imatinib Sandoz, Filmtabletten
CHF 518.95
View
Imatinib Sandoz, Filmtabletten
CHF 1020.45
View
Imatinib Spirig HC, Filmtabletten
CHF 518.95
View
Imatinib Spirig HC, Filmtabletten
CHF 1020.45
View

Other packaging sizes

GLIVEC cpr pell 100 mg sécables 60 pce
60 TABL
View
Buy us a coffee Explore the data